Multiple Myeloma and B Cell Lymphoma. Investigation of IL-6, IL-6 Receptor Antagonist (IL-6RA), and GP130 Antagonist (GP130A) Using Various Parameters in an In Vitro Model
Interleukin-6 (IL-6) affects the survival and proliferation of myeloma cells via autocrine and/or paracrine mechanisms. In this study, we investigated the effects of IL-6, IL-6 receptor antagonist (IL-6RA), and gp130 antagonist (gp130A) on the membrane expressions of IL-6R and gp130, on the viabilit...
Saved in:
Main Author: | Eva Kovacs |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2006-01-01
|
Series: | The Scientific World Journal |
Online Access: | http://dx.doi.org/10.1100/tsw.2006.178 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A GP130-Targeting Small Molecule, LMT-28, Reduces LPS-Induced Bone Resorption around Implants in Diabetic Models by Inhibiting IL-6/GP130/JAK2/STAT3 Signaling
by: Qi-qi Liu, et al.
Published: (2023-01-01) -
Interleukin-6 “Trans-Signaling” and Ischemic Vascular Disease: The Important Role of Soluble gp130
by: Mario Luca Morieri, et al.
Published: (2017-01-01) -
Role of interleukin-15 and interleukin-18 in the secretion of sIL-6R and sgp130 by human neutrophils
by: E. Jablonska, et al.
Published: (2003-01-01) -
Role of soluble gp130 in the tumour necrosis factor-α expression and its production by peripheral blood mononuclear cells
by: E. Jablonskaca, et al.
Published: (2003-01-01) -
Promiscuous Chemokine Antagonist (BKT130) Suppresses Laser-Induced Choroidal Neovascularization by Inhibition of Monocyte Recruitment
by: Shira Hagbi-Levi, et al.
Published: (2019-01-01)